Incidence and Clinical Outcomes of Hypophosphatemia in Patients with Diabetic Ketoacidosis Admitted to a Tertiary Care Hospital
DOI:
https://doi.org/10.36283/ziun-pjmd14-4/076Keywords:
Diabetic Ketoacidosis, Hypophosphatemia, Phosphates, Electrolyte ImbalanceAbstract
Background: Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes mellitus characterized by hyperglycemia, ketosis, and acidosis. Hypophosphatemia is a frequently overlooked yet clinically significant electrolyte disturbance during DKA management. This study aimed to determine the incidence of hypophosphatemia in DKA patients and assess its association with clinical outcomes.
Method: A descriptive cross-sectional study was conducted over six months 1st February, 2025 to 31st July, 2025 at Lady Reading Hospital and Khyber Teaching Hospital, Peshawar. A total of 150 patients aged ≥15 years admitted with DKA were enrolled using non-probability consecutive sampling. Serum phosphate levels were measured at admission and 24 hours after insulin therapy. Hypophosphatemia was defined as serum phosphate <2.5 mg/dL. Clinical outcomes such as muscle weakness, respiratory distress, altered consciousness, arrhythmias, ICU admission, and duration of hospitalization were recorded. Data were analyzed using SPSS version 26. Chi-square test and Mann–Whitney U test were applied.
Results: Hypophosphatemia was observed in 58.7% of DKA patients. Muscle weakness was significantly more common in hypophosphatemic patients (p = 0.026). Although altered consciousness, arrhythmias, and respiratory distress were more prevalent in this group, the differences were not statistically significant. Mean hospital stay was significantly longer among hypophosphatemic patients (p < 0.001). A significant association was also found between the severity of hypophosphatemia and muscle weakness (p = 0.027).
Conclusions: Hypophosphatemia is a prevalent and clinically relevant complication in DKA, associated with increased morbidity and prolonged hospitalization. Routine monitoring and timely management may improve outcomes.
References
REFERENCES
1. Mohajan D, Mohajan HK. Diabetic ketoacidosis (DKA): a severe diabetes mellitus disorder. Studies in Social Science & Humanities. 2023;2(9):29-34.
2. Holt RI, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes care. 2021;44(11):2589-625.
3. Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nature Reviews Disease Primers. 2020;6(1):40.
4. Desai D, Mehta D, Mathias P, Menon G, Schubart UK. Health care utilization and burden of diabetic ketoacidosis in the US over the past decade: a nationwide analysis. Diabetes care. 2018;41(8):1631-8.
5. Khan N, Zaman H, Khan M, Khan F, Anwar M, Qureshi MAJ. Clinical Profile and Out Come of Diabetic Keto Acidosis in Emergency. Healthy Lifestyle Can Reduce the Alzheimer’s Disease. 2022;33(8):115.
6. Su D, Li J, Guo M, Li Y, Ma S. Clinical Analysis of Electrolyte Disorders in Patients with Diabetic Ketoacidosis. Clinical Laboratory. 2021;67(1).
7. Gal A, Odunayo A. Diabetes ketoacidosis and hyperosmolar hyperglycemic syndrome in companion animals. Veterinary Clinics: Small Animal Practice. 2023;53(3):531-50.
8. van Der Vaart A, Waanders F, van Beek AP, Vriesendorp TM, Wolffenbuttel BH, van Dijk PR. Incidence and determinants of hypophosphatemia in diabetic ketoacidosis: an observational study. BMJ open diabetes research & care. 2021;9(1).
9. Adhikari S, Mamlouk O, Rondon-Berrios H, Workeneh BT. Hypophosphatemia in cancer patients. Clinical Kidney Journal. 2021;14(11):2304-15.
10. Attokaran AG, White KC, Doola Re, McIlroy P, Senthuran S, Luke S, et al. Epidemiology of hypophosphatemia in critical illness: A multicentre, retrospective cohort study. Anaesthesia Critical Care & Pain Medicine. 2024;43(5):101410.
11. Aljuhani NR, Alamoudi NM, Majali NB, Algouzi RM, Alzubaidi FA, Alnajri SM. Characteristics and outcome of severe diabetic ketoacidosis in East Jeddah Hospital, Saudi Arabia. Nature. 2021;122(3075):538-.
12. Paul S, Debnath S, Singh AK, Mishra S, Rajotiya S, Singh M, et al. Epidemiologic pattern and factors associated with adverse outcomes of diabetic ketoacidosis in medical intensive care units of a tertiary care centre in India. Endocrine and Metabolic Science. 2024;16:100204.
13. Ata F, Khan AA, Khamees I, Mohammed BZ, Barjas HH, Muthanna B, et al. Differential evolution of diabetic ketoacidosis in adults with pre-existent versus newly diagnosed type 1 and type 2 diabetes mellitus. BMC Endocrine Disorders. 2023;23(1):193.
14. Ricci Z, Diaferia L, Iacopetti G, Pelagatti F. Disorders of Fluid, Electrolytes, and Acid Base Balance. Nutrition, Metabolism and Kidney Support: A Critical Care Approach: Springer; 2024. p. 27-42.
15. de Sa PN, Narayanan M, Lim MAC. Electrolyte and Acid-Base Abnormalities After Kidney Transplantation. Advances in Kidney Disease and Health. 2024;31(5):450-7.
16. bin Razali MH, Hussain S, bin Kamaruzaman MH, binti Ambak NJ. The Prevalence of Hypophosphatemia and its Associated Risk Factors in Diabetic Ketoacidosis Patients. Journal of the ASEAN Federation of Endocrine Societies. 2025;40(1):20.
17. Hasan RA, Hesen JZ, Millican N, Pederson JM, Agus MS. Serum Phosphorus and Hypophosphatemia During Therapy of Diabetic Ketoacidosis in Children: Single-Center, Retrospective Cohort 2016–2022. Pediatric Critical Care Medicine. 2025;26(1):e77-e85.
18. Romagnoli C, Iantomasi T, Brandi ML. Impact of X-linked hypophosphatemia on muscle symptoms. Genes. 2022;13(12):2415.
19. Tebben PJ. Hypophosphatemia: a practical guide to evaluation and management. Endocrine Practice. 2022;28(10):1091-9.
20. Yadav S, Yadav J, Kumar S, Singh P. Metabolism of macro-elements (calcium, magnesium, sodium, potassium, chloride and phosphorus) and associated disorders. Clinical applications of biomolecules in disease diagnosis: A comprehensive guide to biochemistry and metabolism: Springer; 2024. p. 177-203.
21. Schirinzi E, Ricci G, Torri F, Mancuso M, Siciliano G. Biomolecules of muscle fatigue in metabolic myopathies. Biomolecules. 2023;14(1):50.
22. Nasrullah A, Azharuddin S, Young M, Kejas A, Dumont T. Endocrine emergencies in the medical intensive care unit. Critical Care Nursing Quarterly. 2022;45(3):266-84.
23. Jin L, Li P, Xu Q, Xie L, Zhang L. Association of hypophosphatemia during continuous kidney replacement therapy and clinical outcomes: a systematic review and meta-analysis. Blood Purification. 2025;54(1):71-80.
24. Younis MFS. Improving Management with Point of Care for Children with Diabetic Ketoacidosis in Emergency Care in Northwest Bank رسالة ماجستير: AAUP; 2022.
25. Baeg SI, Jeon J, Kang D, Na SJ, Cho J, Kim K, et al. Impact of protocolized fluid management on electrolyte stability in patients undergoing continuous renal replacement therapy. Frontiers in Medicine. 2022;9:915072.
26. Dunn BK, Coore H, Bongu N, Brewer KL, Kumar D, Malur A, et al. Treatment challenges and controversies in the management of critically ill diabetic ketoacidosis (dka) patients in intensive care units. Cureus. 2024;16(9).
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
Metrics
How to Cite
